Recently, weve seen an increasing number of studies that show allulose, a low-carb and low-calorie sweetener, can trigger the release of GLP-1, the same hormone that promotes weight loss and stabilizes blood sugar
Though the majority of physicians surveyed had been in practice for more than 10 years, most said they had only started prescribing GLP1RA medications recently
The synergy preserves NAD+ for better cellular outcomes.[7][36] Emerging data suggests benefits in regenerative medicine, where NAD+ regulates aging pathways.[2] At HyperCharge Health, we observe positive results, though more research is needed
5 , e1015 (2014)
1 GLP1/GIP receptor agonists such as Tirzepatide stimulate insulin and suppress glucagon release, thereby lowering blood sugar levels, delaying gastric emptying, reducing appetite cravings, and enhancing satiety